Study guide

9.2 Dispensing-Restricted Nonprescription Products: Pseudoephedrine, Exempt Schedule V & Others

Oregon Multistate Pharmacy Jurisprudence Examination MPJE

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Overview & Oregon Legal Framework

1.1 Oregon MPJE Format, Fees, Blueprint & 2027 Changes 1.2 Federal–Oregon Legal Hierarchy, Agencies & the Board of Pharmacy

2 Chapter 2: Pharmacist & Pharmacist-in-Charge Responsibilities

2.1 Pharmacist Responsibilities, Supervision & Prohibited Practices 2.2 Pharmacist-in-Charge: Qualifications, Duties, Inventories & Self-Inspection

3 Chapter 3: Pharmacy Technicians, Interns & Preceptors

3.1 Pharmacy Technicians (COPT & PT): Licensure, Permitted Tasks & Limits 3.2 Pharmacy Interns & Preceptors: Licensure, Scope & Supervision

4 Chapter 4: Licensure, Renewal, Discipline & Impaired Practitioners

4.1 Pharmacist Licensure by Examination, Score Transfer & Reciprocity 4.2 License Renewal, Continuing Pharmacy Education & Lapse Rules 4.3 Grounds for Discipline, Sanctions & Mandatory Reporting Deadlines 4.4 Impaired Practitioners & the Health Professionals' Services Program (HPSP)

5 Chapter 5: Prescriber Authority & Prescription Requirements

5.1 Prescriber Authority, DEA Registration & Out-of-State Prescriptions 5.2 Non-Controlled Prescriptions: Required Elements, Signatures, Expiration & Refills 5.3 Controlled Substance Prescriptions: Schedules II–V, EPCS, Emergency Orders & Oregon's CV Limit 5.4 Drug-Use Limitations & Special Prescriptions: REMS, Death with Dignity, EPT & Standing Orders 5.5 Legitimate Medical Purpose, Corresponding Responsibility & Red Flags

6 Chapter 6: Pharmacist Clinical Services & Prescriptive Authority

6.1 CDTM, Clinical Pharmacy Agreements, MTM & Laboratory Testing 6.2 Pharmacist Prescribing: Statewide Protocols, the Formulary & General Requirements 6.3 Pharmacist Prescribing of Hormonal Contraception (ORS 689.689) 6.4 Tobacco Cessation Protocol: Training, Screening, NRT & Non-NRT Prescribing 6.5 Vaccine Prescribing & Administration: Age Floors, Protocols, Training & ALERT IIS 6.6 Opioid Overdose Reversal & MOUD: Naloxone Prescribing, Standing Orders, Immunity & Buprenorphine

7 Chapter 7: Counseling, Language Access & Confidentiality

7.1 Patient Counseling: Triggers, Who May Offer or Accept a Refusal & Documentation 7.2 Language Access & Accessibility: Dual-Language Labels, Registry Interpreters & Prescription Readers 7.3 Patient Confidentiality: Oregon Rules, HIPAA, Part 2 & PDMP Privacy

8 Chapter 8: The Dispensing Process

8.1 Prospective Drug Utilization Review: Oregon's Eight Categories, Documentation & Who May Perform It 8.2 Oregon PDMP: Reporting Within 72 Hours, Covered Drugs, Access & Confidentiality 8.3 Prescription Transfers: Oregon's Next-Business-Day Duty & Federal Controlled Substance Limits 8.4 Dispensing Exceptions: 72-Hour Emergency Refills, Continuation of Therapy, Insulin & Declared Emergencies 8.5 Partial Fills: Schedule II (72-Hour, 30-Day CARA & 60-Day LTCF/Terminal) and Schedules III–V 8.6 Prescription Labeling: Oregon Elements, Physical Description, Expiration Dating & Med Paks 8.7 Packaging: PPPA Child-Resistant Containers, Waivers, Exemptions & Oregon's New-Container Rule 8.8 Conditions Prohibiting Dispensing, Quarantine, Returned Drugs & Charitable Reuse

9 Chapter 9: Nonprescription & Restricted Products

9.1 Nonprescription Drugs: Outlet Registration, Drug Facts Labeling & OTC Packaging 9.2 Dispensing-Restricted Nonprescription Products: Pseudoephedrine, Exempt Schedule V & Others

10 Chapter 10: Product Selection: Generic & Biologic Substitution

10.1 Product Selection: Generic Substitution (ORS 689.515) & Biologic Interchange (ORS 689.522)

11 Chapter 11: Acquisition, Records, Inventories & Loss Reporting

11.1 Ordering & Acquiring Controlled Substances: DEA Registration, Form 222, CSOS & the 5% Rule 11.2 Distribution Records, DSCSA, Recalls & Oregon Record Retention 11.3 Controlled Substance Inventories: Oregon's 367-Day, 93-Day, 31-Day & 15-Day Rules 11.4 Theft & Loss Reporting, Disposal, Reverse Distribution & Take-Back Receptacles

12 Chapter 12: Pharmacy Operations, Storage, Security & Special Practice Settings

12.1 Pharmacy Operations: Pharmacist Presence, Policies, Equipment, Signage, Hours & Closures 12.2 Drug Storage & Cold Chain: Temperatures, Monitoring Plans, Excursions & Vaccine Units 12.3 Security & Non-Pharmacist Access: Keys, Double Set-Ups, Institutional Night Access & DEA Controls 12.4 Hazardous Drugs: NIOSH 2024 List, USP 800 Controls, Assessment of Risk & Disposal 12.5 Compounding: OAR 855-183 (June 2026), USP 795/797/800, 503A vs. 503B & Beyond-Use Dates 12.6 Delivery of Drugs: Depots, Mail Delivery, Prescription Lockers, Kiosks & Mobile Pharmacies 12.7 Central Fill, Remote Processing, Telework & Remote Dispensing Site Pharmacies

13 Chapter 13: Drug Outlet Registration, Inspection & Institutional Practice

13.1 Drug Outlet Classes, Registration, Changes of Ownership/Location/Name & Non-Resident Pharmacies 13.2 Inspections, Self-Inspection Forms & Discipline of Drug Outlets 13.3 Institutional & Long-Term Care Practice: Drug Rooms, Night Access, E-Kits, ADCs & ED Prepacks

9.2 Dispensing-Restricted Nonprescription Products: Pseudoephedrine, Exempt Schedule V & Others

Key Takeaways Explain This Topic AI

Pseudoephedrine and ephedrine are Schedule V in Oregon, and since January 1, 2022 they may be sold without a prescription under ORS 475.230.

In Oregon, only a pharmacist, intern or licensed pharmacy technician may sell pseudoephedrine, from behind the pharmacy counter, to buyers 18 or older with government photo ID.

Oregon pseudoephedrine sales must be entered in NPLEx before the sale, are capped at 3.6 g per 24 hours and 9 g per 30 days, and are logged for two years.

A pharmacist may override an NPLEx stop-sale alert only to protect the buyer from imminent bodily harm, and pseudoephedrine is not reported to Oregon's PDMP.

Federal CMEA adds a 7.5 g per 30-day mail-order limit, and in Oregon nonprescription Schedule V products must be stored in the prescription area.

Last updated: October 2026

Why this matters

The blueprint calls out "dispensing-restricted, non-prescription drugs." In Oregon, the leading example is pseudoephedrine (PSE) and ephedrine . Oregon required a prescription for these from 2006 until 2021 HB 2648 took effect on January 1, 2022 . They are still Schedule V controlled substances under Oregon rule (OAR 855-080-0026), so Oregon's restrictions are stricter than the federal Combat Methamphetamine Epidemic Act (CMEA) .

Oregon PSE and ephedrine sales (ORS 475.230; OAR 855-080-0026)

Requirement Oregon rule

Who may sell Only a licensee : a pharmacist, intern , Certified Oregon Pharmacy Technician or Pharmacy Technician. Never a non-licensed clerk

Where stored Behind the pharmacy counter , inaccessible to the public. Oregon doesn't allow the CMEA "locked cabinet on the sales floor" option

Purchaser At least 18 and shows a valid government-issued photo ID

Before the sale Submit the following to the electronic tracking system, the National Precursor Log Exchange (NPLEx) : the date and time; the purchaser's name, address and date of birth; the ID type, number and issuing agency; and the product name and grams of PSE or ephedrine

Stop-sale alert If NPLEx says not to proceed, the sale may not happen. A pharmacist may override the alert only when, in their discretion, the sale is necessary to protect the purchaser from imminent bodily harm

Quantity limits No more than 3.6 grams in 24 hours and 9 grams in 30 days

Log The purchaser signs an electronic or written log with the date, name and grams. The pharmacy keeps it at least two years

Training Staff are trained on the federal and state requirements

Law enforcement access Through a lawfully issued subpoena accepted by the Board (ORS 475.230(5)(c); OAR 855-080-0029)

  • Not in the PDMP PSE and ephedrine are excluded from Oregon's PDMP (ORS 431A.855(4))
  • Federal CMEA baseline (21 U.S.C. 830; 21 CFR 1314)

Daily limit: 3.6 grams of base per purchaser per day.

30-day limit: 9 grams for retail sales, of which no more than 7.5 grams may be by mail order or mobile retail.

Product stored behind the counter or in a locked cabinet .

A logbook (written or electronic) with the purchaser's name, address and signature, the date and time, and the product and quantity, kept 2 years .

Photo ID check.

Retailers self-certify to DEA that employees are trained.

Oregon adds the controlled-substance classification, the licensee-only rule, the behind-the-pharmacy-counter storage, the 18-year age minimum and mandatory real-time electronic blocking.

Nonprescription Schedule V narcotic preparations (21 CFR 1306.26)

Federal law permits a pharmacist to sell certain Schedule V products, such as codeine-containing cough preparations, without a prescription, if state law allows . The federal conditions are:

Only a pharmacist dispenses. A non-pharmacist may complete the cash transaction after the pharmacist has made the decision.

The purchaser is at least 18 and shows identification if not known.

Over 48 hours , no more than 240 mL (8 oz) or 48 dosage units of an opium-containing product, or 120 mL (4 oz) or 24 dosage units of any other Schedule V controlled substance.

A bound record book records each sale. The book is kept 2 years federally, and 3 years under Oregon's general rule .

In Oregon, any nonprescription Schedule V controlled substance must be stored in the prescription area or a secured storage area (OAR 855-041-1020(4)). Remember that Oregon limits prescription Schedule V orders to 6 months and 5 refills (ORS 475.185(3)).

Other restricted or special nonprescription products

Emergency contraception: levonorgestrel 1.5 mg is OTC without age restriction. Ulipristal requires a prescription, which an Oregon pharmacist may issue under the Board's emergency contraception protocol.

Naloxone 4 mg nasal spray: OTC since 2023. Pharmacies must post notice that it is available. A pharmacist must dispense opioid antagonists under OHA's standing order on request.

Gabapentin is prescription-only and unscheduled, but reported to the PDMP. It is a common distractor in "restricted product" questions.

Warning

In Oregon, a non-licensed cashier may not complete a PSE sale , even with NPLEx clearance. ORS 475.230 limits PSE transfers to pharmacists, interns and pharmacy technicians, and the Board's self-inspection form calls out "only licensed personnel may sell."

Worked example: grams of base

Pseudoephedrine HCl 30 mg tablets contain about 24.6 mg of PSE base each (82% base). A 24-tablet box therefore holds about 0.59 g of base. A purchaser could buy six such boxes (about 3.5 g) in a day without exceeding 3.6 g , but a seventh box (about 4.1 g) would exceed the daily limit. NPLEx tracks the totals in grams, which is why the transaction must be entered before the sale.

Exam scenario

A 19-year-old with a valid driver's license asks to buy 120 mg pseudoephedrine ER tablets at an Oregon pharmacy. A COPT enters the purchaser and product details into NPLEx , which returns a stop-sale alert because of earlier purchases. The COPT cannot override it. Only a pharmacist may override, and only to protect the purchaser from imminent bodily harm . That standard is almost never met by nasal congestion, so the sale should be declined, and the pharmacist may recommend a non-PSE alternative.